{"id":13335,"date":"2021-06-09T09:34:40","date_gmt":"2021-06-09T08:34:40","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=13335"},"modified":"2021-10-11T14:37:41","modified_gmt":"2021-10-11T13:37:41","slug":"major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/","title":{"rendered":"Major statements on the antimicrobial resistance &#8220;silent pandemic&#8221; at the G7, by the Health and Finance ministers"},"content":{"rendered":"\n<p>Source : article published on the <a href=\"https:\/\/amr.solutions\/2021\/06\/05\/g7-health-ministers-3-4-june-communique-implications-for-choosing-wisely\/\">AMR.Solutions website<\/a> on June 5, 2021.<\/p>\n\n\n\n<p>The&nbsp;<a href=\"https:\/\/www.g7uk.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">G7<\/a>&nbsp;met in Oxford this past week.  On that occasion, communiques were released from by both the Health and Finance Ministers:<\/p>\n\n\n\n<ul><li>A&nbsp;<a href=\"https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/991581\/G7-health_ministers-communique-oxford-4-june-2021_2.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">general communique<\/a>&nbsp;that includes multiple comments on AMR (see below)<\/li><li>A statement supporting&nbsp;<a href=\"https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/991582\/G7-clinical-trials-charter.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">collaboration on trials<\/a>&nbsp;for therapeutics and vaccines<\/li><\/ul>\n\n\n\n<p>In the general communique, Points 24-31 are about AMR. Points 32-33 then link to the statement on trial collaboration. The communique, detailing the G7 Health Ministers pledges on AMR, covers the following topics:<\/p>\n\n\n\n<ul><li>#24: AMR is important: We need infection and prevention measures to be used.<\/li><li>#25: We appreciate the&nbsp;<a href=\"https:\/\/globalamrhub.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">Global AMR R&amp;D Hub<\/a>,&nbsp;<a href=\"https:\/\/gardp.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">GARDP<\/a>,&nbsp;<a href=\"https:\/\/www.phe.gov\/about\/barda\/Pages\/default.aspx\" target=\"_blank\" rel=\"noreferrer noopener\">BARDA<\/a>,&nbsp;<a href=\"https:\/\/carb-x.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">CARB-X<\/a>,&nbsp;<a href=\"https:\/\/www.repair-impact-fund.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Novo REPAIR<\/a>,&nbsp;<a href=\"https:\/\/www.imi.europa.eu\/\" target=\"_blank\" rel=\"noreferrer noopener\">IMI<\/a>, and the&nbsp;<a href=\"https:\/\/www.amractionfund.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">AMR Action Fund<\/a><\/li><li>#26: We need incentives to secure new antibiotics and their supply chains:<ul><li>\u201cwe will seek to&nbsp;<strong>overcome the economic barriers to an endurable supply of antimicrobial products<\/strong>&nbsp;and to ensure sustainable innovation in antimicrobial R&amp;D<\/li><li>\u201c\u2026&nbsp;<strong>whilst encouraging appropriate provisions for stewardship<\/strong>, diversity and security of supply chains, environmental protection in manufacturing and disposal, and global access.<\/li><li><strong>To achieve this, we will bring together health and finance officials<\/strong>\u2026\u201d<\/li><\/ul><\/li><li>#27: We recognize the value antibiotics bring to healthcare systems and society. As&nbsp;a result,&nbsp;<strong>\u201cWe will develop a set of shared valuation principles, based on public health needs and taking into account the WHO priority pathogen list\u2026\u201d<\/strong><\/li><li>#28: We acknowledge the pressure on supply chains and that this may make&nbsp;it difficult to&nbsp;access to older antibiotics<\/li><li>#29: We recognize the need to&nbsp;strengthen supply chain resilience<\/li><li>#30: Environmental release of antibiotics is a problem that must be addressed<\/li><li>#31: We will work on acceptable environmental standards for manufacturing<\/li><li>#32 and #33: These point to the communique on trial collaboration: In short, coordination is need at multiple levels to ensure that trials are efficient and deliver useful information.<\/li><\/ul>\n\n\n\n<p>The Finance Ministers have also&nbsp;<a href=\"https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/991640\/FMCBGs_communique_-_5_June.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">released a communique<\/a>&nbsp;and in Para. 20 they tackle the need to address AMR as well as pandemic preparedness. Here\u2019s the full text with bullets added for clarity:<\/p>\n\n\n\n<ul><li>\u201cIt is vital to continue learning lessons from Covid-19 and ensure we are better prepared for future pandemics.<\/li><li>\u201cWe look forward to the Pandemic Preparedness Partnership\u2019s Report to G7 Leaders and the G20 High Level Independent Panel\u2019s findings, and will consider their recommendations, particularly on financing mechanisms.<\/li><li>\u201cRecognising the urgent need to avoid a repeat of the Covid-19 crisis, we commit to work together, and with relevant international partners, to improve international coordination and accountability between global health and finance policy makers.<\/li><li><strong>\u201cWe will work together with our health colleagues in the second half of this year, including with industry, to explore proposals for strengthening market incentives for antibiotic drug development to help tackle antimicrobial resistance \u2013 the \u201csilent pandemic\u201d.<\/strong><\/li><li>\u201cWe must act now to secure the health and economic prosperity of our citizens and that of future generations.<\/li><\/ul>\n\n\n\n<p><strong>&nbsp;<\/strong>These communiques can be read as a strong endorsement to confront the growing threat of antimicrobial resistance at a senior political level, resulting in meaningful and concrete actions.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Source : article published on the AMR.Solutions website on June 5, 2021. The&nbsp;G7&nbsp;met in Oxford this past week. On that occasion, communiques were released from by both the Health and Finance Ministers: A&nbsp;general communique&nbsp;that includes multiple comments on AMR (see below) A statement supporting&nbsp;collaboration on trials&nbsp;for therapeutics and vaccines In the general communique, Points 24-31 [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":13341,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Major statements on the antimicrobial resistance &quot;silent pandemic&quot; at the G7, by the Health and Finance ministers - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Major statements on the antimicrobial resistance &quot;silent pandemic&quot; at the G7, by the Health and Finance ministers - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-09T08:34:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-11T13:37:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Silent-pandemic.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"961\" \/>\n\t<meta property=\"og:image:height\" content=\"538\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Major statements on the antimicrobial resistance &#8220;silent pandemic&#8221; at the G7, by the Health and Finance ministers\",\"datePublished\":\"2021-06-09T08:34:40+00:00\",\"dateModified\":\"2021-10-11T13:37:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/\"},\"wordCount\":540,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Silent-pandemic.jpg\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/\",\"name\":\"Major statements on the antimicrobial resistance \\\"silent pandemic\\\" at the G7, by the Health and Finance ministers - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Silent-pandemic.jpg\",\"datePublished\":\"2021-06-09T08:34:40+00:00\",\"dateModified\":\"2021-10-11T13:37:41+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Silent-pandemic.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Silent-pandemic.jpg\",\"width\":961,\"height\":538,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Major statements on the antimicrobial resistance &#8220;silent pandemic&#8221; at the G7, by the Health and Finance ministers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Major statements on the antimicrobial resistance \"silent pandemic\" at the G7, by the Health and Finance ministers - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/","og_locale":"en_GB","og_type":"article","og_title":"Major statements on the antimicrobial resistance \"silent pandemic\" at the G7, by the Health and Finance ministers - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2021-06-09T08:34:40+00:00","article_modified_time":"2021-10-11T13:37:41+00:00","og_image":[{"width":961,"height":538,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Silent-pandemic.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Noguez","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Major statements on the antimicrobial resistance &#8220;silent pandemic&#8221; at the G7, by the Health and Finance ministers","datePublished":"2021-06-09T08:34:40+00:00","dateModified":"2021-10-11T13:37:41+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/"},"wordCount":540,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Silent-pandemic.jpg","articleSection":["Actualit\u00e9s"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/","name":"Major statements on the antimicrobial resistance \"silent pandemic\" at the G7, by the Health and Finance ministers - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Silent-pandemic.jpg","datePublished":"2021-06-09T08:34:40+00:00","dateModified":"2021-10-11T13:37:41+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Silent-pandemic.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Silent-pandemic.jpg","width":961,"height":538,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/major-statements-on-the-antimicrobial-resistance-silent-pandemic-at-the-g7-by-the-health-and-finance-ministers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"Major statements on the antimicrobial resistance &#8220;silent pandemic&#8221; at the G7, by the Health and Finance ministers"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-12 17:41:17","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/13335"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=13335"}],"version-history":[{"count":22,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/13335\/revisions"}],"predecessor-version":[{"id":17793,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/13335\/revisions\/17793"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media\/13341"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=13335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=13335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=13335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}